This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1inq
From Proteopedia
(New page: 200px<br /><applet load="1inq" size="450" color="white" frame="true" align="right" spinBox="true" caption="1inq, resolution 2.20Å" /> '''Structure of Minor H...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1inq.jpg|left|200px]]<br /><applet load="1inq" size=" | + | [[Image:1inq.jpg|left|200px]]<br /><applet load="1inq" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1inq, resolution 2.20Å" /> | caption="1inq, resolution 2.20Å" /> | ||
'''Structure of Minor Histocompatibility Antigen peptide, H13a, complexed to H2-Db'''<br /> | '''Structure of Minor Histocompatibility Antigen peptide, H13a, complexed to H2-Db'''<br /> | ||
==Overview== | ==Overview== | ||
| - | The mouse H13 minor histocompatibility (H) Ag, originally detected as a | + | The mouse H13 minor histocompatibility (H) Ag, originally detected as a barrier to allograft transplants, is remarkable in that rejection is a consequence of an extremely subtle interchange, P4(Val/Ile), in a nonamer H2-D(b)-bound peptide. Moreover, H13 peptides lack the canonical P5(Asn) central anchor residue normally considered important for forming a peptide/MHC complex. To understand how these noncanonical peptide pMHC complexes form physiologically active TCR ligands, crystal structures of allelic H13 pD(b) complexes and a P5(Asn) anchored pD(b) analog were solved to high resolution. The structures show that the basis of TCRs to distinguish self from nonself H13 peptides is their ability to distinguish a single solvent-exposed methyl group. In addition, the structures demonstrate that there is no need for H13 peptides to derive any stabilization from interactions within the central C pocket to generate fully functional pMHC complexes. These results provide a structural explanation for a classical non-MHC-encoded H Ag, and they call into question the requirement for contact between anchor residues and the major MHC binding pockets in vaccine design. |
==About this Structure== | ==About this Structure== | ||
| - | 1INQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with DMS as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1INQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=DMS:'>DMS</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1INQ OCA]. |
==Reference== | ==Reference== | ||
| Line 13: | Line 13: | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
| - | [[Category: Almo, S | + | [[Category: Almo, S C.]] |
| - | [[Category: Christianson, G | + | [[Category: Christianson, G J.]] |
[[Category: Grey, H.]] | [[Category: Grey, H.]] | ||
[[Category: Mendoza, L.]] | [[Category: Mendoza, L.]] | ||
| - | [[Category: Nathenson, S | + | [[Category: Nathenson, S G.]] |
| - | [[Category: Ostrov, D | + | [[Category: Ostrov, D A.]] |
[[Category: Palmieri, E.]] | [[Category: Palmieri, E.]] | ||
| - | [[Category: Roden, M | + | [[Category: Roden, M M.]] |
[[Category: Roopenian, D.]] | [[Category: Roopenian, D.]] | ||
[[Category: Shastri, N.]] | [[Category: Shastri, N.]] | ||
| Line 30: | Line 30: | ||
[[Category: minor histocompatibility antigen]] | [[Category: minor histocompatibility antigen]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:13:41 2008'' |
Revision as of 11:13, 21 February 2008
|
Structure of Minor Histocompatibility Antigen peptide, H13a, complexed to H2-Db
Overview
The mouse H13 minor histocompatibility (H) Ag, originally detected as a barrier to allograft transplants, is remarkable in that rejection is a consequence of an extremely subtle interchange, P4(Val/Ile), in a nonamer H2-D(b)-bound peptide. Moreover, H13 peptides lack the canonical P5(Asn) central anchor residue normally considered important for forming a peptide/MHC complex. To understand how these noncanonical peptide pMHC complexes form physiologically active TCR ligands, crystal structures of allelic H13 pD(b) complexes and a P5(Asn) anchored pD(b) analog were solved to high resolution. The structures show that the basis of TCRs to distinguish self from nonself H13 peptides is their ability to distinguish a single solvent-exposed methyl group. In addition, the structures demonstrate that there is no need for H13 peptides to derive any stabilization from interactions within the central C pocket to generate fully functional pMHC complexes. These results provide a structural explanation for a classical non-MHC-encoded H Ag, and they call into question the requirement for contact between anchor residues and the major MHC binding pockets in vaccine design.
About this Structure
1INQ is a Protein complex structure of sequences from Mus musculus with as ligand. Full crystallographic information is available from OCA.
Reference
How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination., Ostrov DA, Roden MM, Shi W, Palmieri E, Christianson GJ, Mendoza L, Villaflor G, Tilley D, Shastri N, Grey H, Almo SC, Roopenian D, Nathenson SG, J Immunol. 2002 Jan 1;168(1):283-9. PMID:11751972
Page seeded by OCA on Thu Feb 21 13:13:41 2008
